Perplexity's post-trained GLM 5.2 preview pairs a cheaper open-source base with a frontier advisor—and it's already live in ...

The NBA Playoffs continue. Get a recap of every series matchup, from the first round to The Finals. NBA.com Staff • NBA Playoffs: Complete coverage • Bracket | Series | Playoff News > 2026 NBA Finals ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Surendra Reddy Kamasani is CTO at IBM, and a leader in AI, cloud, and digital transformation ...

Usama has a passion for video games and a talent for capturing their magic in writing. He brings games to life with his words, and he's been fascinated by games for as long as he's had a joystick in ...

For patients with acute myeloid leukemia (AML) who are 75 years of age or older or who are ineligible for intensive induction chemotherapy, azacitidine or decitabine plus venetoclax is the standard of ...

Abstract: We introduce ESPnet-EZ, an extension of the open-source speech processing toolkit ESPnet, aimed at quick and easy development of speech models. ESPnet-EZ focuses on two major aspects: (i) ...

The FDA on Wednesday approved a new all-oral regimen for newly diagnosed acute myeloid leukemia (AML) in patients ineligible for intensive chemotherapy. The combination of decitabine-cedazuridine ...

Cancer Res (2026) 86 (7_Supplement): 5201. Conventional Chimeric Antigen Receptor (CAR) T-cell therapies for Acute Myeloid Leukemia (AML) face persistent challenges, including limited T-cell fitness, ...

Longtime fans of Minnesota’s pro teams are intensely familiar with the term “playing out the string.” It’s the accepted term for those games late in a season when your team is out of the playoff race ...

New trial data suggest azacitidine-venetoclax may rival 7+3 in AML, shifting induction toward targeted, less toxic combinations. For decades, the “7+3” strategy—comprising 7 days of continuous ...

Optimizing Blinatumomab Access for Low- and Middle-Income Countries: Feasibility of a Shortened, Vial-Sharing, Outpatient Approach for Pediatric ALL We retrospectively analyzed 473 adult patients with ...